NFKB1 and Alzheimer disease: Still, a lot of open questions remain, such as the involved NF-κB subunits/genetic variants, the interplay of glia and neurons, the target genes of NF-κB (gene signature) for healthy and diseased AD neurons, and, finally, the therapy.